Shandong Buchang Pharmaceuticals Co (SHSE:603858) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Shandong Buchang Pharmaceuticals Co Additional Paid-In Capital?

Shandong Buchang Pharmaceuticals Co's annual additional paid-in capital declined from Dec. 2021 (¥3,392 Mil) to Dec. 2022 (¥2,494 Mil) and declined from Dec. 2022 (¥2,494 Mil) to Dec. 2023 (¥0 Mil).

Shandong Buchang Pharmaceuticals Co Additional Paid-In Capital Historical Data

The historical data trend for Shandong Buchang Pharmaceuticals Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Buchang Pharmaceuticals Co Additional Paid-In Capital Chart

Shandong Buchang Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

3,384.61

3,392.36

2,493.90

Shandong Buchang Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															-	2,493.90	-	-	-

Shandong Buchang Pharmaceuticals Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Shandong Buchang Pharmaceuticals Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Shandong Buchang Pharmaceuticals Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Buchang Pharmaceuticals Co Ltd (SHSE:603858) » Definitions » Additional Paid-In Capital

Traded in Other Exchanges

N/A

Address

No. 369, Zhonghua West Road, Shandong Province, Heze, CHN, 274000

Website

http://www.buchang.com

Shandong Buchang Pharmaceuticals Co Ltd is a pharmaceuticals company engaged in drug manufacturing. It specializes in the research and development, production and sale of Traditional Chinese patent medicines, supplemented by fields such as hi-tech industry and health industry. The company offers drugs for cardiac and cerebral vascular disease, diabetes, urinary and digestive disease, respiratory disease, gynecological disease and others. Geographically, the company holds its production bases in Shandong, Shaanxi, Hebei and Northeast China, with its marketing network spreading all over the major provinces of China.

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Headlines

No Headlines